In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

APR Applied Pharma Research SA

www.apr.ch

Latest From APR Applied Pharma Research SA

Pacts In Medtech, Nov/Dec 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech highlights notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we look at industry pacts that were sealed in the final two months of 2017.

Pacts in Medtech Deals

Deals Shaping The Medical Industry, December 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance or Financing. This month’s column covers deals announced in November 2017.

Deals BioPharmaceutical

Deal Watch: Seattle Genetics Adds To Antibody-Drug Conjugate Portfolio

Looking to expand beyond Adcetris, Seattle Genetics pays $250m up front for Immunomedics' Phase I/II ADC for triple-negative breast cancer. Elsewhere in the ADC space, Swiss biotech Novimmune and South Korea's LegoChem are teaming up on a research collaboration.

Deals M & A

FDA Migraine Guidance Offers ‘Alternative’ Trial Design With Patient-Focused Endpoint

Sponsor would need “no pain” result at two hours, but could use patient-identified symptom as co-primary endpoint.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Services
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Gynecological, Urological
  • Metabolic Disorders
  • Neurology, Nervous System
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Applied Pharma Research SA
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • APR Applied Pharma Research SA
  • Senior Management
  • Paolo Galfetti, CEO
    Giorgio Reiner, Dir., R&D
    Alessandro Bossi, Dir., Partnering & Bus. Dev.
    Paolo Tomasi, Dir., Fin.
  • Contact Info
  • APR Applied Pharma Research SA
    Phone: (41) 91 695 70 20
    Via Corti 5
    Balerna, 6828
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register